Medicaid Patients With Lupus Travel Farther To See Specialists
Medicaid is one of the nation's largest insurance programs, covering approximately 55 million people. Yet some studies suggest there is declining physician participation in the program, which limits access to enrolled patients, particularly to specialists. Systemic lupus erythematosus (SLE) is a chronic autoimmune condition whose sufferers face lifelong periods of disease flares and inflammation of numerous organ systems. [click link for full article]
FDA Approves Labeling Update For ORENCIA (abatacept) To Inhibit Structural Joint Damage In Adults With Moderate To Severe Rheumatoid Arthritis
Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approved an update to the ORENCIA (abatacept) product labeling regarding the progression of structural joint damage -- an important measure in the treatment of rheumatoid arthritis (RA). [click link for full article]
